IRIS Accounts Production v25.2.0.378 12264331 Board of Directors Board of Directors 6.4.24 5.4.25 5.4.25 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh122643312024-04-05122643312025-04-05122643312024-04-062025-04-05122643312023-04-05122643312023-04-062024-04-05122643312024-04-0512264331ns15:EnglandWales2024-04-062025-04-0512264331ns14:PoundSterling2024-04-062025-04-0512264331ns10:Director12024-04-062025-04-0512264331ns10:Director22024-04-062025-04-0512264331ns10:PrivateLimitedCompanyLtd2024-04-062025-04-0512264331ns10:SmallEntities2024-04-062025-04-0512264331ns10:AuditExempt-NoAccountantsReport2024-04-062025-04-0512264331ns10:SmallCompaniesRegimeForDirectorsReport2024-04-062025-04-0512264331ns10:SmallCompaniesRegimeForAccounts2024-04-062025-04-0512264331ns10:FullAccounts2024-04-062025-04-0512264331ns10:OrdinaryShareClass12024-04-062025-04-0512264331ns10:Director32024-04-062025-04-0512264331ns10:Director42024-04-062025-04-0512264331ns10:Director52024-04-062025-04-0512264331ns10:Director62024-04-062025-04-0512264331ns10:RegisteredOffice2024-04-062025-04-0512264331ns5:CurrentFinancialInstruments2025-04-0512264331ns5:CurrentFinancialInstruments2024-04-0512264331ns5:Non-currentFinancialInstruments2025-04-0512264331ns5:Non-currentFinancialInstruments2024-04-0512264331ns5:ShareCapital2025-04-0512264331ns5:ShareCapital2024-04-0512264331ns5:RetainedEarningsAccumulatedLosses2025-04-0512264331ns5:RetainedEarningsAccumulatedLosses2024-04-0512264331ns5:PlantMachinery2024-04-062025-04-0512264331ns5:LandBuildings2024-04-0512264331ns5:PlantMachinery2024-04-0512264331ns5:LandBuildings2024-04-062025-04-0512264331ns5:LandBuildings2025-04-0512264331ns5:PlantMachinery2025-04-0512264331ns5:LandBuildings2024-04-0512264331ns5:PlantMachinery2024-04-0512264331ns5:WithinOneYearns5:CurrentFinancialInstruments2025-04-0512264331ns5:WithinOneYearns5:CurrentFinancialInstruments2024-04-0512264331ns5:Secured2025-04-0512264331ns5:Secured2024-04-0512264331ns10:OrdinaryShareClass12025-04-05
REGISTERED NUMBER: 12264331 (England and Wales)















PARTNERSHEALTH 2020 LTD

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 5 APRIL 2025






PARTNERSHEALTH 2020 LTD (REGISTERED NUMBER: 12264331)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 5 APRIL 2025




Page

Company Information 1

Statement of Financial Position 2 to 3

Notes to the Financial Statements 4 to 6


PARTNERSHEALTH 2020 LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 5 APRIL 2025







DIRECTORS: Dr M F D Jelpke
Ms S G Lyon
Dr N A Fraser
Dr N P Cartwright
Dr L A Ovenden
Dr G Sahota





REGISTERED OFFICE: Partnershealth 2020 Ltd Cotgrave Surgery
The Cotgrave Hub, Rivermead
Cotgrave
Nottingham
NG12 3UQ





REGISTERED NUMBER: 12264331 (England and Wales)





ACCOUNTANTS: Duncan & Toplis Limited
18 Northgate
Sleaford
Lincolnshire
NG34 7BJ

PARTNERSHEALTH 2020 LTD (REGISTERED NUMBER: 12264331)

STATEMENT OF FINANCIAL POSITION
5 APRIL 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 816,052 810,031

CURRENT ASSETS
Stocks 4,568 4,082
Debtors 5 523,355 463,183
Cash at bank 1,151,502 1,103,295
1,679,425 1,570,560
CREDITORS
Amounts falling due within one year 6 545,959 538,367
NET CURRENT ASSETS 1,133,466 1,032,193
TOTAL ASSETS LESS CURRENT LIABILITIES 1,949,518 1,842,224

CREDITORS
Amounts falling due after more than one year 7 (452,109 ) (469,827 )

PROVISIONS FOR LIABILITIES (3,347 ) (1,748 )
NET ASSETS 1,494,062 1,370,649

CAPITAL AND RESERVES
Called up share capital 9 4 4
Retained earnings 1,494,058 1,370,645
SHAREHOLDERS' FUNDS 1,494,062 1,370,649

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 5 April 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 5 April 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

PARTNERSHEALTH 2020 LTD (REGISTERED NUMBER: 12264331)

STATEMENT OF FINANCIAL POSITION - continued
5 APRIL 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 10 September 2025 and were signed on its behalf by:




Ms S G Lyon - Director



Dr M F D Jelpke - Director


PARTNERSHEALTH 2020 LTD (REGISTERED NUMBER: 12264331)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 5 APRIL 2025

1. STATUTORY INFORMATION

Partnershealth 2020 Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 15% on reducing balance

Tangible fixed assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended.

Stocks
Stocks are valued at the lower of cost and estimated selling price less costs to complete and sell and after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 100 (2024 - 97 ) .

PARTNERSHEALTH 2020 LTD (REGISTERED NUMBER: 12264331)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 5 APRIL 2025

4. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 6 April 2024 800,972 13,432 814,404
Additions - 8,683 8,683
At 5 April 2025 800,972 22,115 823,087
DEPRECIATION
At 6 April 2024 - 4,373 4,373
Charge for year - 2,662 2,662
At 5 April 2025 - 7,035 7,035
NET BOOK VALUE
At 5 April 2025 800,972 15,080 816,052
At 5 April 2024 800,972 9,059 810,031

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 381,993 372,928
Other debtors 141,362 90,255
523,355 463,183

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Bank loans and overdrafts 17,000 17,000
Trade creditors 112,086 75,043
Taxation and social security 114,246 128,635
Other creditors 302,627 317,689
545,959 538,367

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2025 2024
£    £   
Bank loans 452,109 469,827

Amounts falling due in more than five years:

Repayable by instalments
Bank loans due in more than 5
years 385,109 402,827
385,109 402,827

PARTNERSHEALTH 2020 LTD (REGISTERED NUMBER: 12264331)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 5 APRIL 2025

8. SECURED DEBTS

The following secured debts are included within creditors:

2025 2024
£    £   
Bank loans 469,109 486,827

The bank loan is secured against the Gamston Medical Centre.

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
4 Ordinary £1 4 4